Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
+44 1223 790975
ISSN: 2155-9570
+44 1223 790975
Samer Hamada
Queen Victoria Hospital, United Kingdom
Keynote: J Clin Exp Ophthalmol
Dry eye disease is one of the most common eye conditions that every ophthalmologist and pharmacist face in their daily practice. The history of dry eye management is very interesting. Our approach has changed over the years from merely treating dry eye symptoms towards addressing the root problem and the pathophysiogy of the disease. The International Dry Eye workshop reports (DEWS) has changed the way we diagnose, manage, and predict prognosis of dry eye disease. The future holds a very promising therapy to dry eye patients. I will cover the past, current, and future therapies of dry eye disease with focus on medicinal treatment.
Samer Hamada is a highly trained and experienced Consultant Ophthalmologist and Cornea Surgeon with special interest in cornea, cataract and laser and lens refractive surgeries in adults and children. He has over 20 years experience in ophthalmology. His areas of expertise include laser refractive surgery, intraocular lens (non-laser) refractive surgery, advanced cataract surgery, intraocular lens procedures including premium lenses (multifocal, toric, or phakic lenses) and management of laser refractive surgery complications. Pioneer in managing corneal diseases in children he is one of the very few eye surgeons in the world who have educational, academic and clinical skills to manage corneal diseases in children. He was awarded as a distinguished Ophthalmologist in contribution to the new advances in Ophthalmology. He has received the distinguished achievement award from the American Academy of Ophthalmology in 2013 which in addition to many awards and prizes that he earned as a result of his excellence in patients’ care. He is a Teacher, Educator and Lecturer at many international eye conferences.